Literature DB >> 7417350

Effects of some nonsteroidal antiinflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage.

M J Palmoski, K D Brandt.   

Abstract

The effects on proteoglycan metabolism and aggregation of several nonsteroidal antiinflammatory drugs commonly used in the treatment of arthritis were examined in cultures of normal canine articular cartilage. Fenoprofen and ibuprofen inhibited net proteoglycan synthesis in a concentration-dependent fashion. At concentrations in the culture medium comparable to plasma concentrations seen in patients after oral administration in humans, net proteoglycan synthesis in the presence of these drugs averaged 72% and 86% of the control values, respectively (P < 0.01). In contrast, indomethacin and sulindac sulfoxide had no effect on proteoglycan synthesis, while sulindac sulfide stimulated synthesis in a non-concentration dependent fashion (average, 13%). In the presence of ibuprofen or sulindac sulfide, catabolism of sulfated glycosaminoglycans was the same as that in control cartilage, while fenoprofen decreased the rate of degradation slightly. The proportion of newly synthesized proteoglycans existing as aggregates and the average hydrodynamic size of disaggregated proteoglycans were unaffected by ibuprofen, indomethacin, sulindac sulfide, or sulindac sulfoxide. Fenoprofen, on the other hand, interfered with the ability of the cartilage hyaluronic acid to interact with proteoglycans to form aggregates, whereas it had no effect on the in vitro association of proteoglycans with hyaluronic acid from umbilical cord.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7417350     DOI: 10.1002/art.1780230908

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

Review 1.  Drug-induced rheumatic disorders: incidence, prevention and management.

Authors:  P Vergne; P Bertin; C Bonnet; C Scotto; R Trèves
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

2.  In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?

Authors:  R J Rooney; W W Buchanan
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

3.  Decrease of inorganic blood sulfate following treatment with selected antirheumatic drugs: potential consequence for articular cartilage.

Authors:  B J de Vries; P M van der Kraan; W B van den Berg
Journal:  Agents Actions       Date:  1990-03

4.  Matching the Drug to the Patient: The rational use of antiarthritic drugs.

Authors:  P Lee
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

5.  Effects of tiaprofenic acid and other NSAIDs on proteoglycan metabolism in articular cartilage explants.

Authors:  H Muir; S L Carney; L G Hall
Journal:  Drugs       Date:  1988       Impact factor: 9.546

6.  Effects of sodium naproxen on differentiated human chondrocytes cultivated in clusters.

Authors:  C Bassleer; Y Henrotin; P Franchimont
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

Review 7.  'Chondroprotection' by non-steroidal anti-inflammatory drugs.

Authors:  M Doherty
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

8.  The effect of local corticosteroid or ketorolac exposure on histologic and biomechanical properties of rabbit tendon and cartilage.

Authors:  Paul S Shapiro; Rachel S Rohde; Mark I Froimson; Richard H Lash; Paul Postak; A Seth Greenwald
Journal:  Hand (N Y)       Date:  2007-05-05

9.  The effect of chronic paracetamol administration to rats on the glycosaminoglycan content of patellar cartilage.

Authors:  P M van der Kraan; E L Vitters; B J de Vries; W B van den Berg; L B van de Putte
Journal:  Agents Actions       Date:  1990-03

10.  Proteoglycan metabolism in isolated chondrocytes from human cartilage. Influence of niflumic acid.

Authors:  G Verbruggen; E M Veys; A M Malfait; L Schatteman; N Wieme; J Nimmegeers; M G Gerin; C Broddelez
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.